2 studies found for:    16885550 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 Mutations
Condition: Diabetes Mellitus
Intervention: Drug: Sulfonylurea
2 Not yet recruiting Glibentek in Patients With Neonatal Diabetes Secondary to Mutations in K+-ATP Channels
Condition: Neonatal Diabetes Secondary to Mutation in the Potassium Channel
Intervention: Drug: Glibenclamide

Indicates status has not been verified in more than two years